Phospholemman antibody
Principal name
Phospholemman antibody
Alternative names for Phospholemman antibody
FXYD1, PLM, FXYD domain-containing ion transport regulator 1
Available reactivities
Available hosts
Available applications
Enzyme Immunoassay (E), Western blot / Immunoblot (WB)
Background of Phospholemman antibody
This gene encodes a member of a family of small membrane proteins that share a 35-amino acid sigture sequence domain, beginning with the sequence PFXYD and containing 7 invariant and 6 highly conserved amino acids. The approved human gene nomenclature for the family is FXYD-domain containing ion transport regulator. Mouse FXYD5 has been termed RIC (Related to Ion Channel). FXYD2, also known as the gamma subunit of the ,K-ATPase, regulates the properties of that enzyme. FXYD1 (phospholemman), FXYD2 (gamma), FXYD3 (MAT-8), FXYD4 (CHIF), and FXYD5 (RIC) have been shown to induce channel activity in experimental expression systems. Transmembrane topology has been established for two family members (FXYD1 and FXYD2), with the N-terminus extracellular and the C-terminus on the cytoplasmic side of the membrane. The protein encoded by this gene is a plasma membrane substrate for several kises, including protein kise A, protein kise C, NIMA kise, and myotonic dystrophy kise. It is thought to form an ion channel or regulate ion channel activity. Transcript variants with different 5' UTR sequences have been described in the literature. [provided by RefSeq, Jul 2008].
Primary Antibodies
| Catalog No. | Host | Iso. | Clone | Pres. | React. | Applications | |
|---|---|---|---|---|---|---|---|
| AM11023PU-N | Phospholemman antibody |
||||||
 |
Mouse | IgG1 | 41AT858.235 | Purified | Ms | WB |
0.4 ml /
€415.00
|
| OriGene Technologies GmbH | |||||||
Proteins & Growth Factors
| Catalog No. | Species | Pres. | Purity | Source | |
|---|---|---|---|---|---|
| TP307475 | Phospholemman (transcript variant a) |
||||
| Recombinant protein of human FXYD domain containing ion transport regulator 1 (FXYD1), transcript variant a | |||||
 |
Human | > 80 % Preparation: Recombint protein was captured through anti-DDK affinity column followed by conventiol chromatography steps. Purity Detail: > 80% as determined by SDS-PAGE and Coomassie blue staining. |
HEK293 cells |
20 µg /
€748.00
|
|
| OriGene Technologies, Inc. | |||||
Lysates
| Catalog No. | ||
|---|---|---|
| LY402884 | FXYD1 overexpression lysate |
|
 |
0.1 mg /
€295.00
|
|
| OriGene Technologies, Inc. | ||
| LY417593 | FXYD1 overexpression lysate |
|
|
0.1 mg /
€295.00
|
|
| OriGene Technologies, Inc. |
Mouse Lenti ORF Particles
| Catalog No. | ||
|---|---|---|
| MR219730L2V | Lenti ORF particles, Fxyd1 (GFP-tagged) - Mouse FXYD domain-containing ion transport regulator 1 (Fxyd1), transcript variant 1, 200 uL, >10^7 TU/mL |
|
|
200 µl /
€930.00
|
|
| OriGene Technologies, Inc. | ||
| MR200238L2V | Lenti ORF particles, Fxyd1 (GFP-tagged) - Mouse FXYD domain-containing ion transport regulator 1 (Fxyd1), transcript variant 5, 200 uL, >10^7 TU/mL |
|
|
200 µl /
€930.00
|
|
| OriGene Technologies, Inc. | ||
| MR219730L1V | Lenti ORF particles, Fxyd1 (Myc-DDK-tagged) - Mouse FXYD domain-containing ion transport regulator 1 (Fxyd1), transcript variant 1, 200 uL, >10^7 TU/mL |
|
|
200 µl /
€830.00
|
|
| OriGene Technologies, Inc. | ||
| MR200238L1V | Lenti ORF particles, Fxyd1 (Myc-DDK-tagged) - Mouse FXYD domain-containing ion transport regulator 1 (Fxyd1), transcript variant 5, 200 uL, >10^7 TU/mL |
|
|
200 µl /
€830.00
|
|
| OriGene Technologies, Inc. | ||
Rat Lenti ORF Particles
| Catalog No. | ||
|---|---|---|
| RR206754L2V | Lenti ORF particles, Fxyd1 (GFP-tagged ORF) - Rat FXYD domain-containing ion transport regulator 1 (Fxyd1), 200 uL, >10^7 TU/mL |
|
|
200 µl /
€930.00
|
|
| OriGene Technologies, Inc. | ||
| RR206754L1V | Lenti ORF particles, Fxyd1 (Myc-DDK-tagged ORF) - Rat FXYD domain-containing ion transport regulator 1 (Fxyd1), 200 uL, >10^7 TU/mL |
|
|
200 µl /
€830.00
|
|
| OriGene Technologies, Inc. | ||